Every-other-day vs once-a-week urethra-sparing prostate SBRT: 5-year results of a randomized phase II trial.
Fiche publication
Date publication
mars 2023
Journal
International journal of radiation oncology, biology, physics
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERTAUT Aurélie
Tous les auteurs :
Zilli T, Jorcano S, Bral S, Symon Z, Rubio C, Bruynzeel A, Ibrahimov R, Minn H, Oliveira A, Bertaut A, Constantin G, Miralbell R
Lien Pubmed
Résumé
To present the 5-year results from a prospective multicenter phase II randomized trial of every-other-day (EOD) vs. once-a-week (QW) urethra-sparing stereotactic body radiotherapy (SBRT) for localized prostate cancer.
Mots clés
Overall Treatment Time, Prostate cancer, Quality of life, Stereotactic body radiotherapy, Urethra-sparing
Référence
Int J Radiat Oncol Biol Phys. 2023 03 29;: